In addition, studies have also found [29] that inhibiting RIPK1 and RIPK3 levels in ischemic stroke patients can reduce infarct volume and improve the degree of neurological deficits, indirectly confirming that poor prognosis in stroke patients may be related to abnormal expression of RIPK1 and RIPK3 levels. The gene discussed is RIPK3; the disease is stroke disorder.